Daihan Pharmaceutical Co.,Ltd.
KOE: 023910.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sungyoung Lee
- Employees
- 675
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩167B
- Website
- https://www.daihan.com
Loading 023910…
Loading profile data…Frequently asked questions about 023910
What does Daihan Pharmaceutical Co.,Ltd. (023910.KQ) do?
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Where does 023910.KQ trade?
Daihan Pharmaceutical Co.,Ltd. (023910.KQ) trades on the KOSDAQ.
What sector is 023910.KQ in?
Daihan Pharmaceutical Co.,Ltd. (023910.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Daihan Pharmaceutical Co.,Ltd.?
Sungyoung Lee is the chief executive officer of Daihan Pharmaceutical Co.,Ltd. (023910.KQ).
Where is Daihan Pharmaceutical Co.,Ltd. headquartered?
Daihan Pharmaceutical Co.,Ltd. is headquartered in South Korea.
Does 023910.KQ pay a dividend?
Yes — Daihan Pharmaceutical Co.,Ltd. (023910.KQ) paid a trailing twelve-month dividend of KRW 900.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 023910.KQ go public?
Daihan Pharmaceutical Co.,Ltd. (023910.KQ) completed its initial public offering in 2000.